Author:
Prasher Parteek,Sharma Mousmee,Kapoor Deepak N.,Negi Poonam,Gupta Gaurav,Zacconi Flavia C.,Tambuwala Murtaza M.,Mehta Meenu,Satija Saurabh,Dureja Harish,Chellappan Dinesh Kumar,Dua Kamal
Reference63 articles.
1. Agre N, Khambete M, Maitra A, Gupta A, Munshi T, Bhakta S, Degani M (2020) Exploration of 5-(5-nitrothiophen-2-yl)-4,5-dihydro-1H-pyrazoles as selective, multitargeted antimycobacterial agents. Chem Biol Drug Des 95:192–199
2. Alavinezhad A, Khazdair MR, Boskabady MH (2018) Possible therapeutic effect of carvacrol on asthmatic patients: a randomized, double blind, placebo-controlled, phase II clinical trial. Phytother Res 32:151–159
3. Bailey A, Mete A, Pairaudeau G, et al. (2009) New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder. CN101490003A
4. Baker D, Bruce M, Crater G, et al. (2012) Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist. CN102724974A
5. Baxter A, Steele J, Teague S (2005) Use of indole-3-acetic acids in the treatment of asthma, COPD and other diseases. US 2005/0101612 A1